Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 1455

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.


Publication type: Journal Article

Bardelay D, Bécel B.
Visits from medical representatives: fine principles, poor practice
Prescrire International 1995; 4:(18):120-122


Despite recent changes in France such as provisions for professional cards, specific training requirements, compulsory qualifications, ethical codes of practice, the European directive and French legislation on drug advertising and anti-gift legislation, Prescrire’s medical sales representative monitoring network has seen no evidence of an improvement: 13% of detailers quote excessively high doses; side effects, contraindications and interactions are not mentioned in 71-82% of visits and when doctors ask about side effects they obtain an answer in about 75% of cases. For about a year there has been a tendency for companies to promote drugs that have been licensed in France but are not yet on the market. When sales of drugs with doubtful efficacy begin to wane promotion of off-license uses knows no bounds.

*analytic survey France sales representatives quality of information safety & risk information la revue Prescrire EVALUATION OF PROMOTION: DETAILING


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend